Previous 10 | Next 10 |
2023-05-16 17:23:00 ET Gainers: National Western Life Group ( NWLI ) +17% . Extreme Networks ( EXTR ) +7% . Lyell Immunopharma ( LYEL ) +5% . PacWest Bancorp ( PACW ) +5% . Spruce Biosciences ( SPRB ) +5% . Losers: EVgo...
2023-05-15 12:06:59 ET Spruce Biosciences press release ( NASDAQ: SPRB ): Q1 GAAP EPS of -$0.40. Revenue of $1.96M. For further details see: Spruce Biosciences GAAP EPS of -$0.40, revenue of $1.96M
CAHmelia Program in Adult Classic Congenital Adrenal Hyperplasia (CAH) Achieves 50% Enrollment in CAHmelia-204 and Approaches 75% Enrollment in CAHmelia-203 Enrollment in P.O.W.E.R. Study for Polycystic Ovary Syndrome (PCOS) Complete – Topline Results Anticipated in Q3 2023 ...
Mitchell Geffner, M.D., to Present on May 7, 2023 from 12:30 pm – 2 pm PT Spruce Biosciences, Inc . (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical nee...
2023-03-16 16:50:48 ET Spruce Biosciences press release ( NASDAQ: SPRB ): FY GAAP EPS of -$1.96 beats by $0.05 . Cash, cash equivalents and investments as of December 31, 2022 were $79.1 million, excluding $53.6 million in gross proceeds from the February 2023 private ...
CAHmelia-203 in Adult Classic CAH Surpasses 50% Enrollment Private Placement Financing of $53.6 million in Gross Proceeds with Top-Tier Healthcare Investors Strategic Partnership and Exclusive Licensing Agreement with Kaken Pharmaceutical to Develop and Commercialize Tildacerfont ...
Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today announced that Javier Szwarcberg, M.D., M.P.H., Chief Executive Officer, will prese...
If you’re looking for penny stocks to buy, you might want to get a second opinion. You could go to places like Fintwit or Reddit to discover what the mom-and-pop investors are speculating on. Another way to see varying perceptions of companies is to find out what analysts think. Using ...
Why Trade Penny Stocks? Penny stocks are shares of small companies that trade for less than $5 per share. They are seen as an attractive investment option for smaller investors or those with limited capital. That’s due to their affordability and the potential for high returns. Here are...
Spruce Biosciences ( NASDAQ: SPRB ) has raised approximately $53.6M in a private placement financing . Under the securities purchase agreement, the investors have agreed to purchase around 16.1M shares of the company’s common stock and accompanying warrants to purchase up t...
News, Short Squeeze, Breakout and More Instantly...
Spruce Biosciences Inc. Company Name:
SPRB Stock Symbol:
NASDAQ Market:
Spruce Biosciences Inc. Website:
Spruce Biosciences, Inc . (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for endocrine and neurological disorders with significant unmet medical need, announced that the San Francisco Business Times and the Silicon Valley Busines...
Pairs Spruce’s Investigational Product Candidate, Tildacerfont, with HMNC’s Companion Diagnostic, the Proprietary Cortibon Genetic Selection Tool, to Treat MDD Patients Responsive to CRF 1 Receptor Antagonism Provides Spruce with Option to In-License Exclusive Worldwide ...
Significant Reduction in Dehydroepiandrosterone Sulfate ( DHEAS) Versus Placebo Observed in Women with Elevated DHEAS Levels at Baseline Increase in Serum Sex Hormone Binding Globulin (SHBG) Versus Placebo Observed Tildacerfont was Well-Tolerated with No Safety Signals ...